Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.5 - $31.51 $51 - $63
2 Added 0.02%
10,030 $286,000
Q1 2024

May 08, 2024

BUY
$27.7 - $35.48 $193 - $248
7 Added 0.07%
10,028 $293,000
Q4 2023

Feb 09, 2024

SELL
$26.32 - $34.31 $553,009 - $720,887
-21,011 Reduced 67.71%
10,021 $338,000
Q3 2023

Nov 09, 2023

SELL
$30.68 - $40.09 $642,838 - $840,005
-20,953 Reduced 40.31%
31,032 $952,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $47.5 $122,952 - $161,690
3,404 Added 7.01%
51,985 $2.08 Million
Q1 2023

May 09, 2023

SELL
$35.53 - $43.38 $18,582 - $22,687
-523 Reduced 1.07%
48,581 $1.98 Million
Q4 2022

Feb 13, 2023

BUY
$38.19 - $57.45 $280,811 - $422,429
7,353 Added 17.61%
49,104 $1.9 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $16,960 - $19,492
331 Added 0.8%
41,751 $2.22 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $155,448 - $246,471
3,019 Added 7.86%
41,420 $2.42 Million
Q1 2022

May 12, 2022

BUY
$60.03 - $76.49 $284,242 - $362,180
4,735 Added 14.06%
38,401 $2.93 Million
Q4 2021

Feb 11, 2022

SELL
$47.97 - $62.21 $1,918 - $2,488
-40 Reduced 0.12%
33,666 $2.03 Million
Q3 2021

Nov 10, 2021

SELL
$54.64 - $61.3 $4,316 - $4,842
-79 Reduced 0.23%
33,706 $1.89 Million
Q2 2021

Aug 12, 2021

SELL
$59.18 - $69.99 $2,485 - $2,939
-42 Reduced 0.12%
33,785 $2.05 Million
Q1 2021

May 12, 2021

BUY
$59.31 - $78.82 $10,260 - $13,635
173 Added 0.51%
33,827 $2.37 Million
Q4 2020

Feb 12, 2021

BUY
$50.47 - $66.26 $24,578 - $32,268
487 Added 1.47%
33,654 $2.01 Million
Q3 2020

Nov 12, 2020

BUY
$51.97 - $63.0 $621,769 - $753,732
11,964 Added 56.43%
33,167 $1.99 Million
Q2 2020

Aug 11, 2020

BUY
$30.8 - $52.47 $6,375 - $10,861
207 Added 0.99%
21,203 $1.11 Million
Q1 2020

May 14, 2020

BUY
$28.4 - $50.7 $194,483 - $347,193
6,848 Added 48.4%
20,996 $704,000
Q4 2019

Feb 11, 2020

BUY
$36.31 - $46.83 $944 - $1,217
26 Added 0.18%
14,148 $641,000
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $503,590 - $635,348
14,122 New
14,122 $538,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.